Types of Cancer We Treat

Pancreatic Cancer

Our highly experienced and knowledgable team of dedicated doctors combine innovative therapies, precision treatment, and evidence-based medicine to provide world-class care to people with pancreatic cancer. Our specialists are at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

Our experts create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies. Learn more about our comprehensive care for pancreatic cancer at Perlmutter Cancer Center’s Pancreatic Cancer Center.

Find a Doctor & Schedule
Diagnosis
Surgery
Chemotherapy & Targeted Drugs
Radiation Therapy

Related News

Grant Supports Study of the Role of Oxygen in Cancer Cells
Read Story
Exercise Counters Pancreatic Cancer
Read Story
Experimental Pancreatic Cancer Treatment Shows Promise
Read Story
Cancer Cells Are Protected by Abnormal Collagen Buildup
Read Story
Raising Awareness & Increasing Survival of Certain Cancers
Read Story
Genetic Testing Important for People with Pancreatic Cancer
Read Story
Surgical Oncologist Discusses Pancreatic Cancer
Read Story
Early Detection Can Stop Pancreatic Cancer Before It Starts
Read Story
A Surgeon’s Quest to Cure Pancreatic Cancer
Read Story
Pancreatic Cancer Surgeon Works to Improve Disease Control
Read Story
Prototype Shows Promise in Countering Pancreatic Cancer
Read Story
Dr. Christopher Wolfgang Joins NYU Langone Health
Read Story

Clinical Trials and Research Studies

Phase 3

A randomized double-blind phase III study comparing NIS793 in combination with gemcitabine and nab-paclitaxel versus placebo combined with gemcitabine and nab-paclitaxel for first line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC)

Learn More

Phase 2

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil Leucovorin and Liposomal Irinotecan in Older Patients with Treatment Na ve Metastatic Pancreatic Cancer (GIANT) ( s21-00700)

Learn More

Phase 2

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1 BRCA2 or PALB2 Mutation

Learn More

Phase 5

A Phase 1b/2 Randomized Study of AVB-S6-500 Plus Nab-paclitaxel and Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Learn More
View All Related Clinical Trials (10)